ACQUIREDStale
Eton Pharmaceuticals Inc · NASDAQ
+50,000 sh · $189.0K
Filed 31 Aug 2026SEC Form 4view source
- REDUCEDStale
Eton Pharmaceuticals Inc · NASDAQ
−36,387 sh · $2.1M
Filed 31 Aug 2026SEC Form 4view source - REDUCEDStale
Eton Pharmaceuticals Inc · NASDAQ
−13,485 sh · $811.9K
Filed 31 Aug 2026SEC Form 4view source - ACQUIREDStale
Eton Pharmaceuticals Inc · NASDAQ
+12,500 sh · $91.4K
Filed 31 Aug 2026SEC Form 4view source - REDUCEDStale
Eton Pharmaceuticals Inc · NASDAQ
−128 sh · $7.9K
Filed 31 Aug 2026SEC Form 4view source